Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

被引:702
|
作者
Goedert, Michel [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
MULTIPLE-SYSTEM ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; GENOME-WIDE ASSOCIATION; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; NEURODEGENERATIVE-DISEASES; LEWY BODIES; EXPERIMENTAL TRANSMISSION; IDENTIFIES VARIANTS; COMMON VARIANTS;
D O I
10.1126/science.1255555
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathological assembly of Ab, tau, and alpha-synuclein is at the heart of Alzheimer's and Parkinson's diseases. Extracellular deposits of Ab and intraneuronal tau inclusions define Alzheimer's disease, whereas intracellular inclusions of alpha-synuclein make up the Lewy pathology of Parkinson's disease. Most cases of disease are sporadic, but some are inherited in a dominant manner. Mutations frequently occur in the genes encoding Ab, tau, and alpha-synuclein. Overexpression of these mutant proteins can give rise to disease-associated phenotypes. Protein assembly begins in specific regions of the brain during the process of Alzheimer's and Parkinson's diseases, from where it spreads to other areas.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson's and Alzheimer's diseases
    Shalash, A.
    Salama, M.
    Makar, M.
    Roushdy, T.
    El-Balkimy, M.
    MOVEMENT DISORDERS, 2018, 33 : S800 - S801
  • [2] Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases
    Braak, Heiko
    Del Tredici, Kelly
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (11):
  • [3] The Concept of Subconsciousness in Alzheimer's and Parkinson's Diseases
    Agid, Yves
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (03) : 643 - 645
  • [4] Distinct Conformers of Assembled Tau in Alzheimer's and Pick's Diseases
    Goedert, Michel
    Falcon, Benjamin
    Zhang, Wenjuan
    Ghetti, Bernardino
    Scheres, Sjors H. W.
    BRAINS AND BEHAVIOR: ORDER AND DISORDER IN THE NERVOUS SYSTEM, 2018, 83 : 163 - 171
  • [5] β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
    Bing Xu
    Kang Xiao
    Xiaoxi Jia
    Rundong Cao
    Donglin Liang
    Ruhan A
    Weiwei Zhang
    Chunjie Li
    Liping Gao
    Cao Chen
    Qi Shi
    Xiaoping Dong
    Alzheimer's Research & Therapy, 17 (1)
  • [6] Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
    Nirale, Prabhuti
    Paul, Ankita
    Yadav, Khushwant S.
    LIFE SCIENCES, 2020, 245
  • [7] Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)
    Kozlowski, Henryk
    Luczkowski, Marek
    Remelli, Maurizio
    Valensin, Daniela
    COORDINATION CHEMISTRY REVIEWS, 2012, 256 (19-20) : 2129 - 2141
  • [8] Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases
    Milisav, Irina
    Suput, Dusan
    Ribaric, Samo
    MOLECULES, 2015, 20 (12) : 22718 - 22756
  • [9] Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies
    Cehlar, Ondrej
    Njemoga, Stefana
    Horvath, Marian
    Cizmazia, Erik
    Bednarikova, Zuzana
    Barrera, Exequiel E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [10] Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases
    Salama, Mohamed
    Shalash, Ali
    Magdy, Alshimaa
    Makar, Marianne
    Roushdy, Tamer
    Elbalkimy, Mahmoud
    Elrassas, Hanan
    Elkafrawy, Passent
    Mohamed, Wael
    Abou Donia, Mohamed B.
    PLOS ONE, 2018, 13 (05):